by TractManager | May 26, 2016 | Emerging Technology Report
An oral B-cell lymphoma-2 inhibitor initially proposed for single-agent use to treat relapsed or refractory chronic lymphocytic leukemia in patients harboring the 17p deletion.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | May 26, 2016 | Health Technology Assessment
Purpose of Technology: Optical coherence tomography (OCT) relies on detection of reflected infrared light to generate a highly detailed, magnified view of a thin layer of tissue. This technology has been adapted to percutaneous catheters and is being used to examine...
by TractManager | May 26, 2016 | Health Technology Assessment
Purpose of Technology: Bronchial thermoplasty is a minimally invasive treatment that uses heat to reduce the smooth muscle in the lungs that constricts the airway during asthma attacks. This procedure is intended for treatment of severe, persistent asthma in patients...
by TractManager | May 19, 2016 | Health Technology Assessment
Purpose of Technology: The purpose of panniculectomy is to remove a panniculus, a large fold of redundant abdominal skin and subcutaneous fat that forms in obese individuals. Because it can hang down over the pubis and groin, a panniculus may cause various skin...
by TractManager | May 19, 2016 | Health Technology Assessment
Purpose of Technology: Drug-eluting stents (DES) are a device/drug combination product consisting of a coronary stent coated in an antiproliferative drug. Stents are placed within an obstructed artery during percutaneous coronary intervention (PCI) to reestablish...
Recent Comments